Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study

BackgroundPrevious prediction algorithms for cardiovascular diseases (CVD) were established using risk factors retrieved largely based on empirical clinical knowledge. This study sought to identify predictors among a comprehensive variable space, and then employ machine learning (ML) algorithms to develop a novel CVD risk prediction model. MethodsFrom a longitudinal population-based cohort of UK Biobank, this study included 473 611 CVD-free participants aged between 37 and 73 years old. We implemented an ML-based data-driven pipeline to identify predictors from 645 candidate variables covering a comprehensive range of health-related factors and assessed multiple ML classifiers to establish a risk prediction model on 10-year incident CVD. The model was validated through a leave-one-center-out cross-validation. ResultsDuring a median follow-up of 12.2 years, 31 466 participants developed CVD within 10 years after baseline visits. A novel UK Biobank CVD risk prediction (UKCRP) model was established that comprised 10 predictors including age, sex, medication of cholesterol and blood pressure, cholesterol ratio (total/high-density lipoprotein), systolic blood pressure, previous angina or heart disease, number of medications taken, cystatin C, chest pain and pack-years of smoking. Our model obtained satisfied discriminative performance with an area under the receiver operating characteristic curve (AUC) of 0.762 +/- 0.010 that outperformed multiple existing clinical models, and it was well-calibrated with a Brier Score of 0.057 +/- 0.006. Further, the UKCRP can obtain comparable performance for myocardial infarction (AUC 0.774 +/- 0.011) and ischaemic stroke (AUC 0.730 +/- 0.020), but inferior performance for haemorrhagic stroke (AUC 0.644 +/- 0.026). ConclusionML-based classification models can learn expressive representations from potential high-risked CVD participants who may benefit from earlier clinical decisions.